FTI Consulting, Inc.
FCN
$184.03
+0.38%
FTI Consulting, Inc. is a global business advisory firm providing professional services across five segments: corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications, primarily serving clients in the United States. The company is a leading independent player in the niche consulting services industry, known for its expertise in complex corporate restructurings, disputes, and investigations. The current investor narrative centers on a potential value opportunity, as recent institutional buying activity signals confidence in the stock despite recent price weakness, juxtaposed against the company's delivery of record earnings, suggesting the market may be undervaluing its fundamental performance.…
FCN
FTI Consulting, Inc.
$184.03
Related headlines
Investment Opinion: Should I buy FCN Today?
Rating & Thesis: Hold. FCN is a fundamentally sound company with accelerating growth and strong cash flow, but its recent surge to technical resistance and full valuation warrant a pause, awaiting either a better entry point or confirmation of sustained momentum. The lack of a broad analyst consensus makes it difficult to anchor a strong Buy or Sell view, but the single analyst's estimated EPS of $12.20 provides a baseline for valuation.
Supporting Evidence: The stock trades at a forward P/E of 16.57x, which is reasonable but not cheap for a professional services firm, and a PEG ratio of 2.47 indicates high growth expectations. Revenue growth accelerated to 10.71% YoY in Q4, and profitability is improving, with net margin expanding year-over-year. The company generates robust free cash flow ($166.6M TTM) and has a strong balance sheet (D/E 0.34). However, the stock's 10.24% one-month surge and proximity to its 52-week high suggest near-term upside may be limited.
Risks & Conditions: The two biggest risks are a failure to break above $184 resistance leading to a technical pullback, and a deceleration in the high-growth Corporate Finance segment. This Hold rating would upgrade to a Buy on a successful breakout above $184 with volume, or a pullback to the $160-$165 support zone where the forward P/E would become more compelling. It would downgrade to a Sell if quarterly revenue growth decelerates below 5% or if operating margins contract significantly. Relative to its own history and growth profile, the stock is fairly valued to slightly overvalued in the near term.
Sign up to view all
FCN 12-Month Price Forecast
The outlook for FCN is balanced between strong fundamentals and a fully valued, technically extended stock price. The base case of consolidation and steady growth is most probable (55%). The bull case depends on a breakout and sustained high growth, which is possible but less certain (30%). The bear case, while lower probability (15%), carries a clear downside to the $149 support level. The stance is neutral due to the conflicting signals of strong business performance and a stock price at resistance. We would upgrade to bullish on a confirmed breakout above $184 with strong volume, or downgrade to bearish on a breakdown below the $170 support level on disappointing earnings.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FTI Consulting, Inc.'s 12-month outlook, with a consensus price target around $239.24 and implied upside of +30.0% versus the current price.
Average Target
$239.24
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$147 - $239
Analyst target range
Analyst coverage for FCN appears limited, with data indicating only one analyst providing estimates for revenue and EPS, which is insufficient to derive a meaningful consensus recommendation or target price distribution. The single analyst estimates revenue of $4.53 billion and EPS of $12.20 for the period in view. The lack of broad coverage typically characterizes a mid-cap company like FCN ($5.4B market cap) that may fly under the radar of many large institutional research desks. With minimal analyst coverage, a definitive target price range and consensus sentiment cannot be established. The implications of limited coverage are significant: it can lead to higher stock price volatility and less efficient price discovery, as fewer professional opinions are shaping market expectations. This environment can create opportunities for investors who perform their own fundamental work, as the stock may be more prone to mispricing relative to its covered peers. The recent news of a major institutional investor making a substantial bet aligns with this dynamic, suggesting sophisticated actors may see value where broader Wall Street attention is lacking.
Bulls vs Bears: FCN Investment Factors
The evidence currently leans bullish, driven by accelerating revenue growth, record earnings, strong technical momentum, and a valuation that is reasonable relative to its own history. The bear case is primarily technical, citing overextension near 52-week highs, and fundamental, citing limited analyst visibility. The single most important tension in the investment debate is whether the company's recent 10.71% revenue growth and margin improvement can be sustained to justify its forward P/E of 16.57x and high PEG ratio of 2.47, or if the stock's surge to resistance represents a near-term peak before consolidation. The resolution of this growth sustainability question will determine if the stock breaks out to new highs or retraces.
Bullish
- Strong Revenue Growth Acceleration: Q4 2025 revenue grew 10.71% YoY to $990.7 million, a significant acceleration from prior periods. This consistent top-line expansion, led by the Corporate Finance segment ($423.2M), supports a growth investment case amid robust demand for advisory services.
- Record Earnings & Improving Profitability: The company delivered record earnings with Q4 2025 net income of $54.5 million. The net margin improved to 5.5% from 5.55% a year ago, demonstrating an ability to convert revenue growth into earnings despite the high-cost structure of a professional services firm.
- Exceptional Technical Momentum & Low Beta: The stock gained 10.24% over the past month while the S&P 500 fell 4.28%, showing +14.52% relative strength. Its beta of -0.012 indicates virtually no correlation to the market, offering portfolio diversification and suggesting its rally is driven by company-specific fundamentals.
- Strong Balance Sheet & Cash Generation: The company maintains a robust financial position with a low debt-to-equity ratio of 0.34 and a current ratio of 1.56. It generated $166.6M in trailing twelve-month free cash flow, providing ample liquidity for operations and share repurchases without excessive financial risk.
Bearish
- Vulnerable at 52-Week High Resistance: The stock is trading at $183.33, just 0.4% below its 52-week high of $184.06. This positioning suggests bullish sentiment is stretched, increasing vulnerability to a technical pullback if it fails to decisively break through the $184 resistance level.
- Limited Analyst Coverage & Visibility: Only one analyst provides estimates, indicating limited Wall Street coverage for this $5.4B market cap company. This can lead to higher volatility, less efficient price discovery, and increased risk of mispricing due to a lack of professional scrutiny and consensus targets.
- Moderate Margins for Professional Services: Gross margin of 31.05% and operating margin of 9.43% in Q4 2025, while improving, are typical for a high-talent, project-based firm. This business model is inherently exposed to personnel cost inflation, which can pressure profitability if not fully passed to clients.
- High PEG Ratio Suggests Growth Priced In: The PEG ratio of 2.47 is significantly above the traditional value threshold of 1.0. This indicates the market is already pricing in substantial future earnings growth, leaving less margin for error if growth decelerates or fails to meet elevated expectations.
FCN Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 13.68% 1-year price change, but is currently consolidating near its 52-week highs. With a current price of $183.33, it is trading at approximately 99.6% of its 52-week high of $184.06, indicating significant momentum but also potential for overextension and resistance. The stock's positioning near the top of its range suggests bullish sentiment is strong, but it also increases vulnerability to a pullback if it fails to break through the $184 resistance level decisively. Recent short-term momentum is exceptionally strong and diverges positively from the broader market, with a 10.24% gain over the past month compared to the S&P 500's -4.28% decline, resulting in a relative strength of +14.52%. This 1-month surge contrasts with a more modest 7.66% gain over the past 3 months, indicating a recent acceleration in bullish momentum. This divergence from the market and the sharp recent uptick could signal a breakout attempt or a final push before a period of consolidation, especially given the stock's low beta of -0.012, which historically suggests minimal correlation with market moves but is currently exhibiting high idiosyncratic strength. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $184.06 and support at the 52-week low of $149.31. A confirmed breakout above $184 would signal a continuation of the uptrend and could target new highs, while a failure and reversal could see a test of lower support levels. The stock's beta of -0.012 indicates it has exhibited virtually no correlation with the S&P 500's movements, making its volatility largely company-specific; this low beta suggests it may offer portfolio diversification benefits but also means its price action is driven by its own fundamentals and news flow rather than macro trends.
Beta
-0.01
-0.01x market volatility
Max Drawdown
-14.8%
Largest decline past year
52-Week Range
$149-$186
Price range past year
Annual Return
+16.5%
Cumulative gain past year
| Period | FCN Return | S&P 500 |
|---|---|---|
| 1m | +9.3% | -2.0% |
| 3m | +3.6% | -4.8% |
| 6m | +12.7% | -2.1% |
| 1y | +16.5% | +30.4% |
| ytd | +8.1% | -3.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCN Fundamental Analysis
Revenue growth is healthy and accelerating, with Q4 2025 revenue of $990.7 million representing a 10.71% year-over-year increase. This growth rate marks a significant acceleration from the prior-year Q4 period. The Corporate Finance segment is the primary growth driver, contributing $423.2 million in the latest period, which is the largest revenue segment. The multi-quarter trend shows consistent top-line expansion, supporting a growth investment case, particularly as demand for advisory services remains robust across economic cycles. The company is solidly profitable, with Q4 2025 net income of $54.5 million and a net margin of 5.5%. Gross margin for the quarter was 31.05%, while the operating margin stood at 9.43%. Profitability metrics have shown improvement year-over-year, as evidenced by the net margin expanding from 5.55% in Q4 2024. The trajectory is positive, with the company converting revenue growth into earnings, though margins are typical for a high-talent, project-based professional services firm where personnel costs are the primary expense. Balance sheet health is strong, with a conservative debt-to-equity ratio of 0.34 and a robust current ratio of 1.56, indicating ample liquidity. The company generates substantial cash flow, with trailing twelve-month free cash flow of $166.6 million. This strong FCF, coupled with a return on equity of 15.62%, demonstrates the company's ability to fund operations and growth internally without excessive reliance on external financing, thereby minimizing financial risk. The healthy cash generation supports ongoing share repurchases, as seen in the cash flow statements.
Quarterly Revenue
$990746000.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$166577000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCN Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 19.86x, while the forward PE is lower at 16.57x. The gap between trailing and forward multiples implies the market expects earnings growth, as the forward multiple prices in anticipated future earnings expansion, likely based on analyst estimates for continued profit growth. Compared to industry averages, FCN's valuation appears mixed. Its trailing PE of 19.86x is not directly comparable without a provided sector average, but its Price-to-Sales (PS) ratio of 1.42x and EV/EBITDA of 12.91x offer alternative lenses. A PS ratio of 1.42x suggests the market values each dollar of sales at a moderate premium, which may be justified by the company's industry-leading position, consistent profitability, and strong cash flow generation relative to many pure consulting firms. Historically, the stock's current trailing PE of 19.86x sits below its own recent historical range observed in the data, which has seen quarterly PE ratios fluctuate from the mid-teens to over 30x in recent years. For instance, the PE was 24.66x at the end of Q4 2025 and 33.84x at the end of Q4 2024. Trading below its own historical average suggests the stock is not at peak valuation optimism and may have room for multiple expansion if growth expectations are met, presenting a relative value opportunity within its own trading history.
PE
19.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: FCN's primary financial risk is not leverage—its debt-to-equity of 0.34 is low—but rather margin pressure inherent to its business model. With a gross margin of 31.05% and an operating margin of 9.43%, the company operates in a high-talent industry where personnel costs are the main expense. Any failure to pass on wage inflation to clients would compress these already moderate margins. Furthermore, revenue concentration in the Corporate Finance segment ($423.2M in Q4) creates cyclical exposure; a downturn in M&A or restructuring activity could disproportionately impact top-line growth, which is critical to justifying its current valuation multiples.
Market & Competitive Risks: The stock's key market risk is valuation compression given its recent surge to 99.6% of its 52-week high. While its trailing P/E of 19.86x is below its own historical peak, its PEG ratio of 2.47 suggests growth is richly priced. A sector rotation away from growth-oriented industrials could trigger multiple contraction. Competitively, the consulting services industry is fragmented and talent-driven, making client and employee retention a constant challenge. The stock's beta of -0.012 indicates it moves independently of the market, which is a diversification benefit but also means it lacks a macro tailwind and its performance is purely company-specific.
Worst-Case Scenario: The most damaging chain of events would involve a simultaneous slowdown in corporate advisory demand (hitting the flagship Corporate Finance segment) and a failure to maintain pricing power, leading to a double miss on revenue and margins. This could trigger analyst downgrades (though coverage is sparse) and a rapid derating from its current forward P/E of 16.57x towards its historical lows. The realistic downside would be a retreat to its 52-week low of $149.31, representing a potential loss of approximately -18.5% from the current price of $183.33. A more severe but plausible bear case could see a drawdown matching the stock's recent maximum of -14.82%, pushing the price towards $156.
FAQ
The key risks are: 1) Technical/Price Risk: The stock is at resistance ($184.06), making it vulnerable to a pullback; its recent max drawdown was -14.82%. 2) Business Cyclicality: Revenue is concentrated in the Corporate Finance segment, which is tied to M&A and restructuring activity that can decline in an economic slowdown. 3) Margin Pressure: As a professional services firm, rising consultant wages could compress its 9.43% operating margin if not offset by pricing. 4) Limited Visibility: With only one analyst providing estimates, the stock suffers from lower institutional scrutiny, which can lead to higher volatility and mispricing.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock consolidating between $175 and $190, driven by steady mid-single-digit growth. The Bull Case (30% probability) targets $195 to $210 on a successful breakout and sustained high growth, leading to multiple expansion. The Bear Case (15% probability) warns of a retreat to the $149 to $165 range if growth decelerates and technical support fails. The most likely outcome is the Base Case, which assumes the company maintains its current operational momentum without a significant acceleration or deterioration.
FCN is fairly valued to slightly overvalued on a near-term basis. Its forward P/E of 16.57x is reasonable for a firm with its growth profile, but the high PEG ratio of 2.47 suggests the market is pricing in significant future growth. Compared to its own history, where P/Es have ranged into the 30s, the current trailing multiple of 19.86x is not excessive. The Price-to-Sales ratio of 1.42x and EV/EBITDA of 12.91x are moderate. The valuation implies the market expects the company to maintain its recent acceleration in growth and profitability. It is not a clear bargain, nor is it egregiously overpriced.
FCN is a good stock for investors who already own it or are seeking a GARP holding with low market correlation, but it is not an ideal buy at the current moment for new money. The company's fundamentals are strong, with 10.71% revenue growth and solid cash flow. However, the stock trades at 99.6% of its 52-week high, leaving little margin for error. The implied upside is contingent on a breakout above $184, while the downside risk is a pullback to support near $160 (-13%). It is a good buy on a pullback or a confirmed breakout, but at current levels, it warrants a Hold rating.
FCN is more suitable for a medium- to long-term investment horizon (12+ months) rather than short-term trading. Its low beta (-0.012) means it doesn't track daily market moves, reducing its appeal for short-term tactical trades. The investment thesis is based on sustained revenue growth and cash flow generation, which are longer-term fundamentals. However, given its current position at technical resistance, short-term traders might await a clearer breakout or pullback. For long-term investors, the strong balance sheet and industry position are attractive, but they should be prepared for volatility due to its cyclical exposure and limited analyst coverage. A minimum holding period of 2-3 years is suggested to ride out business cycles.